Jamal Rushdy, Chief Executive Officer
Jamal brings over 20 years of experience in the medical device industry in successful entrepreneurial and high growth public companies. Jamal has extensive commercial and operational leadership experience including leading global orthopedic and biologics product marketing teams at DJO and Tornier (now Wright Medical), as well as a successful track record of building shareholder value through business development transactions. He has helped achieve successful exits for private equity and angel investors as a founding member or senior executive of four medical device companies. Jamal earned an MBA from U.C. Irvine and a BSME from U.C. San Diego.
Hilary Spence, Chief Financial Officer
Hilary has over 30 years' commercial experience in finance across a number of multi-sector businesses. Over her career Hilary has been involved in a number of successful business transformations where her diverse skills have been used to create, financially evaluate and implement growth strategies. Hilary has worked with a broad range of companies from large corporates including Heineken, Vodafone, Motorola and Premier Foods and smaller more entrepreneurial businesses. Most recently Hilary was Interim CFO at the private equity funded Powerleague, where she was integral to the restructuring and transformation of the finance systems. Hilary is a Chartered Accountant, member of ICAS and has a BA in Business Economics and MBA from Strathclyde University.
Tom Hyland, Chief Operating Officer
Tom has a wealth of experience in the field of collagen chemistry and the development, manufacturing, validation and engineering requirements of collagen-based medical devices. He is a recognised expert in the field as a six sigma black belt, and has played a major role in bringing a number of highly successful collagen-based products to market. Tom has worked with an impressive list of global life science companies, including Johnson and Johnson Wound Management where he was involved in the identification and commercialisation of a series of products which now have global sales exceeding £50m per annum. He was also employed at Microsulis, Intercell, Alere and Invitrogen, in a range of senior operational roles in the areas of Drugs, Diagnostics & Interventional Devices, manufacture scale up and production technology.
Kevin Darling, General Manager New Zealand
Kevin brings extensive experience in operational management to Collagen Solutions, having previously held the General Manager (NZ) and Group General Manager (Australia and NZ) positions for Gribbles Veterinary Pathology Ltd over a period of seven years. Gribbles Veterinary is the leading veterinary pathology service provider in New Zealand, with multiple laboratory sites, each catering to a unique set of regional needs and challenges. Kevin holds a Bachelor of Science in Zoology with a focus on Medical and Veterinary Entomology from the University of Aberdeen. In addition to his educational background and expertise in operational management, Kevin also brings extensive global sales and marketing experience from his tenures at 3M, Mars Confectionery and the BOC Group.
Brad Selman, Vice President Global Sales and Marketing
Brad brings an extensive background in commercial management to Collagen Solutions, with over 16 years’ experience in various commercial roles within the med tech industry. Most recently, Brad was Vice President of Sales and Business Development, Wound Care for Noble Biomaterials, a global manufacturer of silver-based antimicrobials. Prior to Noble Biomaterials, he was Director of Business Development for Molnycke Healthcare in their Advanced Wound Care Division and was responsible for identifying licensing and acquisition opportunities for North America and APAC. Before that, Brad spent 8 years leading sales, marketing and business integration teams at Coloplast A/S, a Danish manufacturer of Ostomy, Continence, Urology and Wound Care products. Brad earned an MBA from the University of Tennessee and a BS in Geology from Juanita College in Pennsylvania.
Chris Wattengel, Vice President Research and Development
Chris brings over 15 years of experience in the medical device industry with a background in the field of regenerative medicine product development. Prior to Collagen Solutions, Chris held R&D leadership positions with Kensey Nash and DSM Biomedical developing materials and products for the orthopedic, biosurgery, and general surgery markets. Chris is a graduate of the University of Rochester where he studied Biomedical Engineering.